May 24 (Reuters) – The U.S. Patent and Trademark Office
(PTO) has begun a trial into whether Belgian pharmaceutical
company UCB’s patent for an epilepsy drug is valid,
said a generic drug company…
The post UCB faces U.S. patent challenge for epilepsy drug appeared first on NASDAQ.